About Biocompatibles
Biocompatibles is a company based in Farnham (United Kingdom) founded in 1998 was acquired by BTG International in November 2010.. The company has 164 employees as of December 31, 2021. Biocompatibles offers products and services including Defibrillators, Pacemakers, and Stents. Biocompatibles operates in a competitive market with competitors including TriSalus Life Sciences, Cooler Heads, Luminate Medical, Embolx and Delcath, among others.
- Headquarter Farnham, United Kingdom
- Employees 164 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biocompatibles Uk Limited
- Date of Incorporation 16 Oct, 2001
- Jurisdiction WEYDON LANE FARNHAM, SURREY
-
Annual Revenue
$175.46 M (USD)32as on Dec 31, 2020
-
Net Profit
$22.7 M (USD)160as on Dec 31, 2020
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
164
as on Dec 31, 2021
-
Acquired by
BTG International
(Nov 19, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biocompatibles
Biocompatibles offers a comprehensive portfolio of products and services, including Defibrillators, Pacemakers, and Stents. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Devices for treating cardiac rhythm disorders
Implants to regulate abnormal heartbeats
Tools for maintaining open blood vessels
Funding Insights of Biocompatibles
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biocompatibles
Biocompatibles has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BTG International. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapeutics are developed for oncology, pulmonology, hematology, and anti-venom treatments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biocompatibles
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biocompatibles
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biocompatibles Comparisons
Competitors of Biocompatibles
Biocompatibles operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TriSalus Life Sciences, Cooler Heads, Luminate Medical, Embolx and Delcath, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of drug delivery devices to treat cancers
|
|
| domain | founded_year | HQ Location |
Developer of cold cap system to prevent chemotherapy side effects
|
|
| domain | founded_year | HQ Location |
Developer of a medical device to prevent hair loss during chemotherapy
|
|
| domain | founded_year | HQ Location |
Catheter-based system for localized cancer therapy is being developed.
|
|
| domain | founded_year | HQ Location |
Delcath Systems, Inc. is focused on liver cancer treatments.
|
|
| domain | founded_year | HQ Location |
Cognos Therapeutics is focused on innovative neurological and oncological treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Biocompatibles
When was Biocompatibles founded?
Biocompatibles was founded in 1998.
Where is Biocompatibles located?
Biocompatibles is headquartered in Farnham, United Kingdom. It is registered at Farnham, Surrey, United Kingdom.
How many employees does Biocompatibles have?
As of Dec 31, 2021, the latest employee count at Biocompatibles is 164.
What is the annual revenue of Biocompatibles?
Annual revenue of Biocompatibles is $175.46M as on Dec 31, 2020.
What does Biocompatibles do?
Founded in 1998 and headquartered in Farnham, United Kingdom, Biocompatibles operates in the biotherapeutics sector. Products focused on oncology, including drug-eluting bead transarterial chemoembolization (TACE) for liver cancer, hepatocellular carcinoma, metastases, and tumors, are provided. The primary product, LC Bead, is used to block blood supply to hypervascularized tumors. Acquisition by BTG occurred in 2011, and a 36 million settlement was paid in 2016 following a lawsuit over promotional activities.
Who are the top competitors of Biocompatibles?
Biocompatibles's top competitors include TriSalus Life Sciences, Cooler Heads and Cognos Therapeutics.
What products or services does Biocompatibles offer?
Biocompatibles offers Defibrillators, Pacemakers, and Stents.
Who are Biocompatibles's investors?
Biocompatibles has 1 investor. Key investors include BTG International.